AKT1 and glioblastoma: Investigating the molecular mechanisms of CK2 in GBM development and progression, the group of Benveniste demonstrated that this kinase is required for the activation of pro-survival pathways, such as Januskinase/Signal Transducers and Activators of Transcription (JAK/STAT) and PI3K/AKT [31,32].